Abstract
There are extensive efforts to develop cell-targeting adenoviral vectors for gene therapy wherein endogenous cell-binding ligands are ablated and exogenous ligands are introduced by genetic means. Although current approaches can genetically manipulate the capsid genes of adenoviral vectors, these approaches can be time-consuming and require multiple steps to produce a modified viral genome. We present here the use of the bacteriophage λ Red recombination system as a valuable tool for the easy and rapid construction of capsid-modified adenoviral genomes.
Original language | English (US) |
---|---|
Pages (from-to) | 1125-1130 |
Number of pages | 6 |
Journal | Human Gene Therapy |
Volume | 15 |
Issue number | 11 |
DOIs | |
State | Published - Nov 2004 |
Externally published | Yes |
ASJC Scopus subject areas
- Molecular Medicine
- Molecular Biology
- Genetics